This strategic transaction allows Nestlé to enter the fast-growing global market for clinical nutrition products tailor-made for people with inherited metabolic disorders.
This sector is growing rapidly, as improved diagnosis and screening enable increasing numbers of cases to be detected, and new advances in science demonstrate the benefits of specialised nutrition as an integral part of clinical management.
Vitaflo has approximate annual sales of CHF 40m. The acquisition price isn’t disclosed.
Source: Nestlé
© FoodBev Media Ltd 2024